Edition:
United Kingdom

Recipharm AB (publ) (RECIb.ST)

RECIb.ST on Stockholm Stock Exchange

152.60SEK
17 Aug 2018
Change (% chg)

-0.20kr (-0.13%)
Prev Close
152.80kr
Open
152.80kr
Day's High
153.00kr
Day's Low
152.40kr
Volume
1,562
Avg. Vol
186,321
52-wk High
168.00kr
52-wk Low
82.80kr

Latest Key Developments (Source: Significant Developments)

Recipharm Q2 EBITDA Rises To SEK 307 Million
Wednesday, 25 Jul 2018 

July 25 (Reuters) - RECIPHARM AB (PUBL) ::APRIL - JUNE 2018* NET SALES AMOUNTED TO SEK 1,701 MILLION (1,401), AN INCREASE OF 21%.Q2 EBITDA SEK 307 MILLION VERSUS SEK 242 MILLION YEAR AGO.  Full Article

Recipharm Partners With Hadasit
Tuesday, 15 May 2018 

May 15 (Reuters) - RECIPHARM AB (PUBL) ::RECIPHARM AND HADASIT PARTNER TO DELIVER SEAMLESS CHEMICAL AND CLINICAL SERVICES.PARTNERED WITH HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT TO OFFER COMBINED CLINICAL, BIOLOGICAL AND CHEMICAL SERVICES..  Full Article

Recipharm Buys Remaining Shares In Nitin Lifesciences
Tuesday, 2 Jan 2018 

Jan 2 (Reuters) - Recipharm Ab (Publ) ::RECIPHARM ACQUIRES REMAINING SHARES IN NITIN LIFESCIENCES LTD.RECIPHARM AB (PUBL) - CONSIDERATION IS INR 2,800 MILLION (SEK 351 MILLION1).RECIPHARM AB (PUBL) - REACHED AN AGREEMENT TO ACQUIRE REMAINING 26 PER CENT OF SHARES OF NITIN LIFESCIENCES LIMITED.RECIPHARM AB (PUBL) - INR 600 MILLION (SEK 75 MILLION1) WILL BE PAID IN NEWLY ISSUED RECIPHARM SHARES (RECI-B).  Full Article

Recipharm Q3 EBITDA down at SEK ‍103​ mln
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - RECIPHARM AB (PUBL) :Q3 NET SALES SEK ‍1.20 BILLION VERSUS SEK 1.14 BILLION YEAR AGO.Q3 EBITDA SEK ‍103​ MILLION VERSUS SEK 144 MILLION YEAR AGO.  Full Article

Recipharm Q3 EBITDA down at SEK ‍103​ mln
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - RECIPHARM AB (PUBL) ::Q3 EBITDA SEK ‍103​ MILLION VERSUS SEK 144 MILLION YEAR AGO.Q3 NET SALES SEK ‍1.20​ BILLION VERSUS SEK 1.14 BILLION YEAR AGO.  Full Article

Recipharm to end operations in two facilities in Sweden
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - RECIPHARM AB (PUBL) ::RECIPHARM TO END OPERATIONS IN TWO FACILITIES IN SWEDEN.‍TO START A PROCESS WITH INTENTION OF DISCONTINUING ACTIVITIES BOTH IN STOCKHOLM AND HÖGANÄS.​.‍WILL EXPLORE OPPORTUNITY TO CLOSE FACILITIES DURING SECOND HALF OF 2019​.SAYS ‍WILL EVALUATE DIFFERENT OPTIONS FOR FACILITY SUCH AS DIVESTMENT OF MANUFACTURING SITE​.‍FINAL DECISION REGARDING DISCONTINUED MANUFACTURING OPERATIONS IN STOCKHOLM AND HÖGANÄS TO BE MADE BEFORE END-2017.‍CLOSURE AFFECTS APPROXIMATELY 225 OF SWEDISH EMPLOYEES​.‍WILL EXPLORE OPPORTUNITY TO CLOSE FACILITIES IN GREATER STOCKHOLM AREA DURING SECOND HALF OF 2019​.‍ESTIMATED NON-RECURRING COSTS ASSOCIATED WITH DECISION TO DISCONTINUE OPERATIONS ARE EXPECTED TO BE CHARGED TO Q4​.‍ESTIMATED NON-RECURRING COSTS ASSOCIATED WITH DECISION TO BE CHARGED TO Q4 RESULTS​.  Full Article

Recipharm says Chief Financial Officer to leave company
Monday, 19 Dec 2016 

Recipharm Ab (Publ) : Says Chief Financial Officer to leave recipharm .Says a search process has commenced to appoint a new CFO..  Full Article

Recipharm places SEK 1,000 mln convertible bonds
Thursday, 29 Sep 2016 

Recipharm Ab (Publ) : Says places SEK 1,000 million senior unsecured convertible bonds .Says the bonds will carry a coupon of 2.75 pct per annum, and have a conversion price set at SEK 181.955.  Full Article

BRIEF-Recipharm Q1 EBITDA Up At SEK 250 Million

* Q1 NET SALES SEK 1.51 BILLION VERSUS SEK 1.33 BILLION YEAR AGO